Hepatitis B viral markers in severe viral hepatitis: Influence of steroid therapy
Harry B. Greenberg, William S. Robinson, C. Michael Knauer, Peter B. Gregory – 1 January 1981 – In our double‐blind randomized trial of methylprednisolone vs. placebo in severe viral hepatitis, 16 patients with hepatitis B (8 on steroid, 8 on placebo) were followed for at least 4 weeks. Four of the eight patients receiving methylprednisolone eventually died and all patients on placebo survived. Despite marked reduction in serum IgG in steroid‐treated patients, the decline in HBsAg titer and disappearance of Dane particle markers was the same in both treatment groups.